What is the address of DOKTER SOPHIE VERELST, PEDIATER?

The registered office of DOKTER SOPHIE VERELST, PEDIATER is located at Dooistraat 39, 3590 Diepenbeek.

Is DOKTER SOPHIE VERELST, PEDIATER still active?

Yes. According to the CBE (17 September 2026) DOKTER SOPHIE VERELST, PEDIATER is active, legal situation “Normale toestand”, started on 18 February 2020.

Is DOKTER SOPHIE VERELST, PEDIATER registered on Peppol?

Yes, DOKTER SOPHIE VERELST, PEDIATER is registered on the Peppol network with ID 0208:0743766702.

What is the enterprise number of DOKTER SOPHIE VERELST, PEDIATER?

The enterprise number of DOKTER SOPHIE VERELST, PEDIATER is BE0743766702.

When was DOKTER SOPHIE VERELST, PEDIATER founded?

DOKTER SOPHIE VERELST, PEDIATER was founded on 18 February 2020.

Who are the directors of DOKTER SOPHIE VERELST, PEDIATER?

According to the 2025 annual accounts, the directors of DOKTER SOPHIE VERELST, PEDIATER are: Sophie Verelst.

Is DOKTER SOPHIE VERELST, PEDIATER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 February 2020; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER SOPHIE VERELST, PEDIATER make in 2025?

DOKTER SOPHIE VERELST, PEDIATER posted a profit after taxes of € 111,417 in financial year 2025.

What is the revenue of DOKTER SOPHIE VERELST, PEDIATER?

As a small company, DOKTER SOPHIE VERELST, PEDIATER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 189,851.

DOKTER SOPHIE VERELST, PEDIATER (Private Limited)

Dossier DOKTER SOPHIE VERELST, PEDIATER, printed on 17 September 2026 from databakkes.be/en/0743766702/dokter-sophie-verelst-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER SOPHIE VERELST, PEDIATER from Diepenbeek, company number BE0743766702, closed financial year 2025 with a result of € 111,417 after tax. For that financial year DOKTER SOPHIE VERELST, PEDIATER recorded a gross margin of € 189,851 and equity of € 625,536. Compared with financial year 2024, the result moved from € 214,884 to € 111,417. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 625,536

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 111,417

▼ 48% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,922

▲ 94% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 624,036.

People and assets in 2025

Vehicles and equipment

€ 24,557

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 73,271

▼ 15% vs 2024

€ 12,998 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 2,323

▼ 11% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,628 Gross margin 2022: € 134,628 First fiscal year in the series	€ 159,356 Gross margin 2023: € 159,356 ▲ 18% vs 2022 (€ 134,628) Favourable step	€ 286,909 Gross margin 2024: € 286,909 ▲ 80% vs 2023 (€ 159,356) Favourable step	€ 189,851 Gross margin 2025: € 189,851 ▼ 34% vs 2024 (€ 286,909) Unfavourable step	▼ 34%
Profit after taxes	€ 93,643 Profit after taxes 2022: € 93,643 First fiscal year in the series	€ 115,781 Profit after taxes 2023: € 115,781 ▲ 24% vs 2022 (€ 93,643) Favourable step	€ 214,884 Profit after taxes 2024: € 214,884 ▲ 86% vs 2023 (€ 115,781) Favourable step	€ 111,417 Profit after taxes 2025: € 111,417 ▼ 48% vs 2024 (€ 214,884) Unfavourable step	▼ 48%
Equity	€ 183,454 Equity 2022: € 183,454 First fiscal year in the series	€ 299,235 Equity 2023: € 299,235 ▲ 63% vs 2022 (€ 183,454) Favourable step	€ 514,119 Equity 2024: € 514,119 ▲ 72% vs 2023 (€ 299,235) Favourable step	€ 625,536 Equity 2025: € 625,536 ▲ 22% vs 2024 (€ 514,119) Favourable step	▲ 22%
Total debts	€ 60,728 Total debts 2022: € 60,728 First fiscal year in the series	€ 76,329 Total debts 2023: € 76,329 ▲ 26% vs 2022 (€ 60,728) Unfavourable step	€ 106,281 Total debts 2024: € 106,281 ▲ 39% vs 2023 (€ 76,329) Unfavourable step	€ 75,593 Total debts 2025: € 75,593 ▼ 29% vs 2024 (€ 106,281) Favourable step	▼ 29%
Cash	€ 138,372 Cash 2022: € 138,372 First fiscal year in the series	€ 80,901 Cash 2023: € 80,901 ▼ 42% vs 2022 (€ 138,372) Unfavourable step	€ 24,745 Cash 2024: € 24,745 ▼ 69% vs 2023 (€ 80,901) Unfavourable step	€ 47,922 Cash 2025: € 47,922 ▲ 94% vs 2024 (€ 24,745) Favourable step	▲ 94%
Land & buildings	€ 0 Land & buildings 2022: € 0 First fiscal year in the series	-	€ 25,040 Land & buildings 2024: € 25,040 First fiscal year in the series	€ 23,773 Land & buildings 2025: € 23,773 ▼ 5% vs 2024 (€ 25,040) Unchanged	▼ 5%
Retained profit	€ 181,954 Retained profit 2022: € 181,954 First fiscal year in the series	€ 297,735 Retained profit 2023: € 297,735 ▲ 64% vs 2022 (€ 181,954) Favourable step	€ 512,619 Retained profit 2024: € 512,619 ▲ 72% vs 2023 (€ 297,735) Favourable step	€ 624,036 Retained profit 2025: € 624,036 ▲ 22% vs 2024 (€ 512,619) Favourable step	▲ 22%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 85,847 Bank debt 2024: € 85,847 Unchanged (€ 0) Unfavourable step	€ 73,271 Bank debt 2025: € 73,271 ▼ 15% vs 2024 (€ 85,847) Favourable step	▼ 15%
Balance sheet total	€ 244,182 Balance sheet total 2022: € 244,182 First fiscal year in the series	€ 375,564 Balance sheet total 2023: € 375,564 ▲ 54% vs 2022 (€ 244,182) Unchanged	€ 620,400 Balance sheet total 2024: € 620,400 ▲ 65% vs 2023 (€ 375,564) Unchanged	€ 701,129 Balance sheet total 2025: € 701,129 ▲ 13% vs 2024 (€ 620,400) Unchanged	▲ 13%

Key figures of DOKTER SOPHIE VERELST, PEDIATER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER SOPHIE VERELST, PEDIATER?

What happened at DOKTER SOPHIE VERELST, PEDIATER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2026 New annual accounts for financial year 2025: profit of € 111,417 (▼ 48% vs 2024). filed late Source: NBB ↗
Feb 18, 2020 New establishment in Diepenbeek. KBO
2020 Sophie Verelst became a director. NBB
Feb 18, 2020 Start of the company according to the CBE. KBO

In short

From € 93,643 profit in 2022 to € 111,417 profit in 2025.

Paid € 201,206 in corporate taxes since 2022.

Best year ever: 2024, with € 214,884 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER SOPHIE VERELST, PEDIATER? We notify you, reason included.

Follow DOKTER SOPHIE VERELST, PEDIATER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sophie Verelst

DOKTER SOPHIE VERELST, PEDIATER

Immo Graz 17%

Behind DOKTER SOPHIE VERELST, PEDIATER is Sophie Verelst. It owns 17% of Immo Graz itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Sophie Verelst

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Dooistraat 39

3590 Diepenbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0743.766.702
VAT number: BE 0743.766.702
Registered office: Dooistraat 39, 3590 Diepenbeek
Names & denominations: DOKTER SOPHIE VERELST, PEDIATER · Dr. Sophie Verelst
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 February 2020
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗